284 related articles for article (PubMed ID: 23486609)
21. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
22. Morphometric Analysis in the Diagnosis of Low-Grade Ductal and Lobular Carcinoma in Situ of the Breast.
Parra-Herran C; Hope T; Rashed T; Slodkowska E; Lu FI; Nofech-Mozes S
Anal Quant Cytopathol Histpathol; 2015 Dec; 37(6):331-8. PubMed ID: 26860008
[TBL] [Abstract][Full Text] [Related]
23. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
24. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder SE; Ellis IO
Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
[TBL] [Abstract][Full Text] [Related]
25. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.
Rasbridge SA; Gillett CE; Sampson SA; Walsh FS; Millis RR
J Pathol; 1993 Feb; 169(2):245-50. PubMed ID: 8383197
[TBL] [Abstract][Full Text] [Related]
26. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
27. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
[TBL] [Abstract][Full Text] [Related]
28. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry for diagnosis and prognosis of breast cancer: a review.
Bonacho T; Rodrigues F; Liberal J
Biotech Histochem; 2020 Feb; 95(2):71-91. PubMed ID: 31502889
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
31. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
[TBL] [Abstract][Full Text] [Related]
32. The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Moriya T
J Clin Pathol; 2009 May; 62(5):407-13. PubMed ID: 19126567
[TBL] [Abstract][Full Text] [Related]
33. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
Wagner PL; Kitabayashi N; Chen YT; Shin SJ
Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
[TBL] [Abstract][Full Text] [Related]
34. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA
Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
[TBL] [Abstract][Full Text] [Related]
36. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic utility of the minimal carcinoma triple stain in breast carcinomas.
Ross DS; Liu YF; Pipa J; Shin SJ
Am J Clin Pathol; 2013 Jan; 139(1):62-70. PubMed ID: 23270900
[TBL] [Abstract][Full Text] [Related]
38. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Naidu R; Wahab NA; Yadav MM; Kutty MK
Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
[TBL] [Abstract][Full Text] [Related]
39. Endothelin-1, Endothelin-A- and Endothelin-B-receptor expression in preinvasive and invasive breast disease.
Wülfing P; Diallo R; Kersting C; Wülfing C; Poremba C; Greb RR; Böcker W; Kiesel L
Oncol Rep; 2004 Apr; 11(4):791-6. PubMed ID: 15010874
[TBL] [Abstract][Full Text] [Related]
40. Differentiation between cancerous and normal hyperplastic lobules in breast lesions.
Slater M; Danieletto S; Pooley M; Cheng Teh L; Gidley-Baird A; Barden JA
Breast Cancer Res Treat; 2004 Jan; 83(1):1-10. PubMed ID: 14997049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]